My Consumer Products Guide
SEE OTHER BRANDS

Your consumer products news reporter

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025)

Nanterre, October 21, 2025

Declaration of transactions on treasury shares
(period from 13 to 17 October 2025)

As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250):

Day Total daily volume
(in number of shares)
Weighted average price
(unit daily)
10/16/2025 10,000 €38.05
10/17/2025       489 €38.10
Total 10,489  

As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 of the 24,328,716 shares comprising the company's capital (i.e., 0.04%).

All press releases relating to the share buyback program are published in the "Regulated Information" section (under "Weekly declarations of the share buyback transactions" and "Share buyback programs") of the company's website.

About NEURONES

With over 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible
www.neurones.net

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03

jpbrutin@oconnection.fr


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net

Attachment


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions